You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Patent Applications for erlotinib hydrochloride

✉ Email this page to a colleague

« Back to Dashboard

US Patent Applications for erlotinib hydrochloride

Subscribe to access the full database, or Get Started Free
US Patent Application	Patent No.	Title	Patent Filing Date	Patent Application Status	Status Updated
⤷ Get Started Free	⤷ Get Started Free	Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist	2002-03-04	Abandoned -- Failure to Respond to an Office Action	2007-10-01
⤷ Get Started Free	⤷ Get Started Free	BENZOQUINONE ANSAMYCINS	2002-08-05	Patented Case	2005-03-09
⤷ Get Started Free	⤷ Get Started Free	N- (3-ETHYNYLPHENYL) -6, 7-BIS (2-METHOXYETHOXY) -4-QUINAZOLINAMINE MESYLATE ANHYDRATE AND MONOHYDRATE	2003-11-17	Patented Case	2009-04-01
⤷ Get Started Free	⤷ Get Started Free	Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapy	2003-11-14	Abandoned -- Failure to Respond to an Office Action	2008-01-07
⤷ Get Started Free	⤷ Get Started Free	NOVEL [6,7-BIS(2-METHOXY-ETHOXY)-QUINAZOLIN-4-YL]-(3-ETHYNYL-PHENYL)AMINE HYDROCHLORIDE POLYMORPH	2004-02-03	Patented Case	2006-11-22
>US Patent Application	>Patent No.	>Title	>Patent Filing Date	>Patent Application Status	>Status Updated

WIPO Patent Applications for erlotinib hydrochloride

Subscribe to access the full database, or Get Started Free
WIPO Patent Application	Title	Patent Filing Date
⤷ Get Started Free
⤷ Get Started Free
⤷ Get Started Free
⤷ Get Started Free
⤷ Get Started Free
>WIPO Patent Application	>Title	>Patent Filing Date

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.